BioSpace News Archive

Business

Legend Biotech Reports First Quarter 2022 Financial Results and Recent Highlights

Legend Biotech today reported its first quarter 2022 unaudited financial results.

June 1, 2022
·
17 min read
Pharm Country

Saneso Novel 360° Colonoscope Receives FDA Clearance

Saneso Inc., a leading US developer of next gen endoscope systems announces today the US Food and Drug Administration (FDA) has granted 510(k) clearance of its novel integrated 360° field of view colonoscope.

June 1, 2022
·
2 min read
Bio NC

Accord Healthcare Releases Generic Drug Proven Effective Against Idiopathic Pulmonary Fibrosis

Accord Healthcare, Inc., a leading generic pharmaceutical company, has added Pirfenidone to its oral solid products portfolio.

June 1, 2022
·
2 min read
Business

ECHO Autism Communities Collaborate with Cognoa to Study Real-World Application of Canvas Dx

Cognoa, a pediatric behavioral health company, is announcing the initiation of a real-world evidence study of its novel AI-based software as a medical device, Canvas Dx, in collaboration with the University of Missouri ECHO Autism Communities Research Team.

June 1, 2022
·
6 min read
Drug Development

Mitsubishi Tanabe Pharma America Presents 48-Week Results from Global Phase 3 Safety Clinical Study of RADICAVA ORS® (edaravone), an Oral Treatment for ALS

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced 48-week results from the global Phase 3 open-label, multi-center clinical trial (MT-1186-A01) assessing the safety and tolerability of RADICAVA ORS® (edaravone) in patients with amyotrophic lateral sclerosis (ALS).

June 1, 2022
·
8 min read
FDA Quality and Regulatory Consultants (FDAQRC) expands into Recruitment

In an effort to answer needs of both clients and career professionals in the life science field, FDAQRC has expanded its service line to include Recruiting.

June 1, 2022
·
1 min read
Lexaria Announces 2022 Annual Meeting Results

Lexaria Bioscience Corp., a global innovator in drug delivery platforms announces the results of the 2022 Annual Meeting.

June 1, 2022
·
4 min read
Qureator Closes $15 Million in Series A Funding to Deliver Improved Disease Modeling and Drug Design Solutions

Animal studies have been used extensively over the years to model the effect of medicinal compounds on the human body.

June 1, 2022
·
2 min read
Genetown

Harbour BioMed Reports the Latest Progress of Next-Generation Fully Human Heavy-chain Antibody HBM4003 with Unique Treg Depletion Mechanism

Harbour BioMed (the “Company”, HKEX: 02142), today announced the progress of its dual MOA of CTLA-4 inhibition and Treg depletion, next-generation fully human heavy-chain antibody (HBM4003) with studies of monotherapy and combination therapy with anti-PD-1 antibody.

June 1, 2022
·
6 min read
Business

Perimeter Medical Imaging AI Appoints Experienced MedTech Executive, Chris Scott, as Chief Financial Officer

Perimeter Medical Imaging AI, Inc. announced the appointment of Chris Scott as Chief Financial Officer, effective immediately.

June 1, 2022
·
5 min read